The FDA has revoked its emergency use authorization for hydroxychloroquine as a treatment for COVID-19 hospital patients, determining that the controversial drug was “unlikely to be effective in treating COVID-19.”

Barcelona health tech investment firm Nina Capital and Oxford Sciences Innovation also contributed during this round of funding, Ultromics announced. 

Doctors involved in the study, who presented during the Society of Interventional Radiology's virtual meeting, say the augmented-reality platform can help physicians and patients better understand their treatment.

It will be more than a year for the U.S. healthcare industry to return to normal, with physicians expecting the new normal to be sometime around August 2021—once a vaccine for COVID-19 has been distributed.

The rule eliminates provisions of a 2016 rule from the Obama administration that attempted to protect trans patients from discrimination.

Researchers have successfully piloted the use of augmented reality for guiding tumor ablation, completing the treatment in five patients with cancers of the liver.

CEO Jim Rechtin said such actions will include “reinvigorating” the Nashville physician firm’s Diversity & Inclusion Committee and creating a plan within the next 60 days to promote change in its service areas. 

With further refinement, the researchers say their convolutional neural network-based platform could help lighten sonographers’ ever-increasing workloads.

Those include the Society of Nuclear Medicine and Molecular Imaging and American College of Radiology, which want a reprieve from training for imaging and localization studies until after the public health crisis. 

The FDA has provided new information about the metformin recall first announced in May.